Latest Breaking News On - மருந்து உருவாக்கம் - Page 1 : comparemela.com

EQS-Adhoc: Kuros Biosciences AG: Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion 05-May-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Grant of European patent entitled Pharmaceutical Formulation for Use in Spinal Fusion Schlieren (Zurich), Switzerland, May 5, 2021 - Kuros Biosciences AG (SIX: KURN), a leader in next generation bone graft technologies, today announced that its subsidiary, Kuros Biosurgery AG, has been granted European patent EP 2686027, entitled Pharmaceutical Formulation for Use in Spinal Fusion . This patent claims certain matrix materials in combination with parathyroid hormone (PTH) or derivatives of PTH.

United kingdomMichael grauMary ann changKuros biosciencesGroup news serviceEqs groupInternational reporting standardSwiss exchangePharmaceutical formulationKuros biosurgeryChief executive officerAd hocஒன்றுபட்டது கிஂக்டம்மைக்கேல் கிறௌமேரி ஆண்டு சாங்குழு செய்தி சேவை